Synergistic Improvement in Children with Cerebral Palsy Who Underwent Double-Course Human Wharton’s Jelly Stem Cell Transplantation

<div>Cells were identified as hWJSCs by fluorescence-activated cell sorting. The percentages of cells expressing MSC markers (CD105, CD90, CD73, and CD44) were all higher than 95%, whereas those of cells expressing non-MSC markers (CD19, CD45, CD11b, and CD34) were no more than 0.1%.</div>

Stem Cells International

fig1

Figure 1

Figure 1: Synergistic Improvement in Children with Cerebral Palsy Who Underwent Double-Course Human Wharton’s Jelly Stem Cell Transplantation 